Market Cap

Orphazyme A/S Market Capitalization:

kr.32.5 Million

DKK as of Jan. 1, 2023

US$4.7 Million

business Orphazyme A/S Company Profile

Orphazyme A/S Main Stock Listing

show_chart OMXC: ORPHA

Market Capitalization History of Orphazyme A/S

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $304.61 B
CSL Limited $93.24 B
Regeneron Pharmaceuticals, Inc. $79.53 B
Marinomed Biotech AG $76.72 B
Vertex Pharmaceuticals Incorporated $74.13 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of Orphazyme A/S market cap

Date Market Cap YoY Change
Jan. 1, 2023 kr.32.5 M -93.35%
Jan. 1, 2022 kr.488.5 M -81.65%
Jan. 1, 2021 kr.2.66 B -42.79%
Jan. 1, 2020 kr.4.65 B 143.86%
Jan. 1, 2019 kr.1.91 B -31.48%
Jan. 1, 2018 kr.2.79 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Orphazyme A/S Categories

Denmark languages Healthcare languages Biotechnology
Denmark Healthcare Denmark Biotechnology

Stocks & Indices

Orphazyme A/S has the following listings and related stock indices.


Stock: OMXC: ORPHA

Stock: NASDAQ: ORPH

Stock: FSX: 1TB

Stock: FSX: 1TBD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.